Podcast

I’m Aware That I’m Rare: Jeff Fineman, MD

06/26/2017

Dr. Jeffrey Fineman is a pediatric critical care specialist, or intensivist, and the division chief of Critical Care at UCSF Benioff Children’s Hospital, San Francisco. He also is an associate investigator of the Cardiovascular Research Institute. His research has led to new therapies for pulmonary hypertension, including a drug called inhaled nitric oxide, which was approved by the US Food and Drug Administration. Fineman's research has focused on diseases related to pulmonary circulation. In particular, he has been interested in the pathophysiology of pulmonary hypertension and heads a laboratory, funded by the National Institutes of Health, for these investigations.

This podcast is published in partnership with PhAware

Read the transcript for this podcast here.

Listen to “I’m Aware That I’m Rare: the phaware™ podcast” at www.phawarepodcast.libsyn.com. Learn more about pulmonary hypertension at www.phaware.global. #phaware

Related Content

medication adherence
medication adherence
George Karpouzas, MD, on the Factors Affecting RA Medication Adherence
02/17/2022
Dr Karpouzas talks about his study that evaluated the influence of distinct domains of rheumatoid arthritis disease activity, functional limitation, mood disturbance, as well as RA-specific knowledge...
02/17/2022
Cardiovascular Diseases
Cardiovascular Diseases
Laxmi Mehta, MD, on the Future of CVD Prevention in Women
12/18/2017
Laxmi Mehta, MD, from the Ohio State University, talks about the CVD prevention methods that are on the horizon for women.
12/18/2017
Chronic Obstructive Pulmonary Disease
Chronic Obstructive Pulmonary Disease
Susan S. Jacobs, RN, MS, on the New Guidelines for Home Oxygen Therapy
12/06/2020
In this podcast, Susan Jacobs, RN, MS, talks about the new American Thoracic Society's Guidelines on Home Oxygen Therapy, what they mean for clinicians and patients with COPD and ILD, as well as the highly...
12/06/2020
Geriatrics
Geriatrics
ANA Investigates Biomarkers for Alzheimer Disease
08/19/2020
David Holtzman, MD, talks about the established biomarkers for Alzheimer disease, potential biomarkers being investigated, and how long it may take for these biomarker tests to make it to the bedside.
08/19/2020
Migraine
Migraine
Matthew Robbins, MD, on the New Migraine Treatments
08/22/2019
In this podcast, Matthew Robbins, MD, overviews the treatments for migraine that are currently available, assesses the risks and benefits of using each treatment in clinical practice, and explains how to...
08/22/2019